SHARE

Pfizer targets $1.5bn in savings by 2027

The pharmaceuticals giant has announced plans for a raft of cost-cutting measures, and has said that it hopes to reduce its expenses by about $1.5bn by the end of 2027, adding to a $4bn cost-savings plan it announced last year.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.